Hawaii Biotech Overview

  • Year Founded
  • 1982

Year Founded

  • Status
  • Out of Business

  • Employees
  • 13

Employees

  • Latest Deal Type
  • Out of Business

Hawaii Biotech General Information

Description

Operator of a biotechnology-based platform intended for recombinant proteins applicable to the development of safe and effective vaccines. The company develops prophylactic vaccines for infectious diseases like Zika, West Nile, dengue, Ebola viruses, and malaria, and small molecule drugs targeting anthrax and botulinum toxins, and treatment of Anthrax intoxication following exposure to Anthrax spores, and for the treatment of botulism, enabling the healthcare sector with support for better treatment and healthcare.

Contact Information

Formerly Known As
Hawaii Biotechnology Group
Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Corporate Office
  • 650 Iwilei Road
  • Suite 204
  • Honolulu, HI 96817
  • United States
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Corporate Office
  • 650 Iwilei Road
  • Suite 204
  • Honolulu, HI 96817
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Hawaii Biotech Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
18. Out of Business 09-Sep-2026 Completed Out of Business
17. Accelerator/Incubator 01-May-2024 Completed Generating Revenue
16. Grant 07-Mar-2023 Completed Generating Revenue
15. Grant 05-Jul-2022 Completed Generating Revenue
14. Debt - PPP 07-Apr-2020 Completed Generating Revenue
13. Grant 21-Sep-2018 Completed Generating Revenue
12. Grant 22-Jul-2016 Completed Generating Revenue
11. Grant 06-Apr-2015 Completed Generating Revenue
10. Grant 04-Feb-2014 $1.1M $36.7M Completed Generating Revenue
9. Bankruptcy: Admin/Reorg 15-Dec-2009 $36.7M Completed Generating Revenue
To view Hawaii Biotech’s complete valuation and funding history, request access »

Hawaii Biotech Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Operator of a biotechnology-based platform intended for recombinant proteins applicable to the development of safe and e
Drug Discovery
Honolulu, HI
13 As of 2026

Taipei, Taiwan
 

Elmsford, NY
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Hawaii Biotech Competitors (18)

One of Hawaii Biotech’s 18 competitors is Abnova (Taiwan), a Corporation company based in Taipei, Taiwan.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Abnova (Taiwan) Corporation Taipei, Taiwan
TechnoVax Corporation Elmsford, NY
Editas Medicine Formerly VC-backed Cambridge, MA
Fulcrum Therapeutics Formerly VC-backed Cambridge, MA
Genentech Formerly VC-backed South San Francisco, CA
You’re viewing 5 of 18 competitors. Get the full list »

Hawaii Biotech Patents

Hawaii Biotech Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-4208198-A2 Recombinant sars-cov-2 spike protein subunits, expression and uses thereof Inactive 04-Sep-2020
EP-4208198-A4 Recombinant sars-cov-2 spike protein subunits, expression and uses thereof Inactive 04-Sep-2020
US-20230312656-A1 Recombinant sars-cov-2 spike protein subunits, expression and uses thereof Inactive 04-Sep-2020
WO-2022051425-A2 Recombinant sars-cov-2 spike protein subunits, expression and uses thereof Inactive 04-Sep-2020
WO-2022051425-A3 Recombinant sars-cov-2 spike protein subunits, expression and uses thereof Inactive 04-Sep-2020 A61K39/12
To view Hawaii Biotech’s complete patent history, request access »

Hawaii Biotech Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Hawaii Biotech Investments (1)

Hawaii Biotech’s most recent deal was a Early Stage VC with Cardax for . The deal was made on 19-Jul-2007.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Cardax 19-Jul-2007 Early Stage VC Drug Discovery
To view Hawaii Biotech’s complete investments history, request access »

Hawaii Biotech FAQs

  • When was Hawaii Biotech founded?

    Hawaii Biotech was founded in 1982.

  • Where is Hawaii Biotech headquartered?

    Hawaii Biotech is headquartered in Honolulu, HI.

  • What is the size of Hawaii Biotech?

    Hawaii Biotech has 13 total employees.

  • What industry is Hawaii Biotech in?

    Hawaii Biotech’s primary industry is Drug Discovery.

  • Is Hawaii Biotech a private or public company?

    Hawaii Biotech is a Private company.

  • What is Hawaii Biotech’s current revenue?

    The current revenue for Hawaii Biotech is .

  • How much funding has Hawaii Biotech raised over time?

    Hawaii Biotech has raised $36.7M.

  • Who are Hawaii Biotech’s competitors?

    Abnova (Taiwan), TechnoVax, Editas Medicine, Fulcrum Therapeutics, and Genentech are some of the 18 competitors of Hawaii Biotech.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process